Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dario A. Dornbierer"'
Autor:
Andrea E. Steuer, Francesco Bavato, Laura K. Schnider, Dario A. Dornbierer, Oliver G. Bosch, Boris B. Quednow, Erich Seifritz, Christian Steuer, Thomas Kraemer
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Gamma-hydroxybutyrate (GHB) remains a challenging clinical/forensic toxicology drug. Its rapid elimination to endogenous levels mainly causes this. Especially in drug-facilitated sexual assaults, sample collection often occurs later than the
Externí odkaz:
https://doaj.org/article/819accab49b84659a5400b487744d9a7
Autor:
Helena D. Aicher, Michael J. Mueller, Dario A. Dornbierer, Dila Suay, Claudius Elsner, Ilhui Wicki, Daniel Meling, Luzia Caflisch, Alexandra Hempe, Camilla Steinhart, Jovin Mueller, Robin Von Rotz, Birgit Kleim, Milan Scheidegger
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2024)
BackgroundThere is growing scientific evidence for the therapeutic benefits of the Amazonian plant-based psychedelic “ayahuasca” for neuropsychiatric disorders such as depression and anxiety. However, there are certain challenges when incorporati
Externí odkaz:
https://doaj.org/article/fbee90a9fd9245d2bd6bf8e1dc38067e
Autor:
Dario A. Dornbierer, Laurenz Marten, Jovin Mueller, Helena D. Aicher, Michael J. Mueller, Martina Boxler, Michael Kometer, Davor Kosanic, Robin von Rotz, Maxim Puchkov, Thomas Kraemer, Hans-Peter Landolt, Erich Seifritz, Milan Scheidegger
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Recently, the Amazonian plant medicine “ayahuasca”—containing the psychedelic compound N,N-dimethyltryptamine (DMT) and numerous β-carboline alkaloids, such as harmine—has been suggested to exhibit beneficial effects in patients with affecti
Externí odkaz:
https://doaj.org/article/85b21ff587c744f29a95712b38d1ede7
Autor:
Dario A. Dornbierer, Firat Yerlikaya, Rafael Wespi, Martina I. Boxler, Clarissa D. Voegel, Laura Schnider, Aslihan Arslan, Diego M. Baur, Markus R. Baumgartner, Tina Maria Binz, Thomas Kraemer, Hans-Peter Landolt
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Sleep inertia is a disabling state of grogginess and impaired vigilance immediately upon awakening. The adenosine receptor antagonist, caffeine, is widely used to reduce sleep inertia symptoms, yet the initial, most severe impairments are ha
Externí odkaz:
https://doaj.org/article/5d46e8cd1eeb4df3b4c16337b30ea4b2
Autor:
Andrea E. Steuer, Justine Raeber, Fabio Simbuerger, Dario A. Dornbierer, Oliver G. Bosch, Boris B. Quednow, Erich Seifritz, Thomas Kraemer
Publikováno v:
Metabolites, Vol 11, Iss 3, p 166 (2021)
In forensic toxicology, gamma-hydroxybutyrate (GHB) still represents one of the most challenging drugs of abuse in terms of analytical detection and interpretation. Given its rapid elimination, the detection window of GHB in common matrices is short
Externí odkaz:
https://doaj.org/article/38aee1b35df94eefb8a88046530874be
Autor:
Francesco Bavato, Fabrizio Esposito, Dario A. Dornbierer, Niklaus Zölch, Boris B. Quednow, Philipp Staempfli, Hans-Peter Landolt, Erich Seifritz, Oliver G. Bosch
Sodium oxybate (γ-hydroxybutyrate, GHB) is an endogenous GHB/GABABreceptor agonist, clinically used to promote slow-wave sleep and reduce next-day sleepiness in disorders such as narcolepsy and fibromyalgia. The neurobiological signature of these un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eeba0df969a2215bb722b4f0dc22990
https://doi.org/10.1101/2022.11.21.22282584
https://doi.org/10.1101/2022.11.21.22282584
